Liabilities / Assets
86th percentile
Higher debt load relative to assets than 86% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.31x
Liabilities / Revenue
81st percentile
Higher debt load relative to revenue than 81% of similar nonprofits.
Net Margin
8th percentile
Higher net margin than 8% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
6th percentile
Faster asset growth than 6% of similar nonprofits.
Revenue Growth
11th percentile
Faster revenue growth than 11% of similar nonprofits.
Balance Sheet
Assets
Down$137,375
Down $233,061 (-63%) from 2020
Net Assets
Down$94,974
Down $268,881 (-74%) from 2020
Liabilities
Up$42,401
Up $35,820 (+544%) from 2020
Revenue And Expenses
Revenue
Down$309,594
Down $612,812 (-66%) from 2020
Expenses
Down$578,474
Down $193,426 (-25%) from 2020
Net Income
Down-$268,880
Down $419,386 (-279%) from 2020
Historical Trend
Filing Detail Status
This 2021 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jul 1, 2020 to Jun 30, 2021
Mission and Program Overview
Mission
Helping texans beat leukemia through patient aid, research, and innovation.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2021 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $137,375
- Liabilities
- $42,401
- Net assets
- $94,974
- Revenue
- $309,594
- Expenses
- $578,474
- Net income
- -$268,880